AIToday
Large Language ModelsAI in HealthcarearXiv cs.LGPublished: May 5, 2026, 13:00 JST1 min read

GAZE framework enables medical vision-language models to iteratively inspect brain MRI images and retrieve literature, reaching 58.2 mAP for lesion localization on rare neurological conditions

3 Key Points

  1. GAZE (Grounded Agentic Zero-shot Evaluation) lets medical vision-language models call viewer-level tools (zoom, windowing, contrast, edge detection) and retrieval tools backed by PubMed and Open-i, with structured outputs validated against a schema and full tool-call traces recorded for auditability.

  2. On NOVA, a benchmark of 906 brain MRI cases covering 281 rare neurological conditions, GAZE reaches 58.2 mean average precision (mAP) at intersection-over-union (IoU) 0.3 for lesion localization and 34.9% Top-1 diagnostic accuracy under a joint protocol scoring captioning, diagnosis, and localization, without task-specific fine-tuning.

  3. Tool use helps rare pathologies disproportionately: the fraction of cases with IoU > 0.3 rises from 17% to 58% for diagnoses with three or fewer examples versus 25% to 68% for common conditions (≥10 cases), with retrieval ablations revealing a model-dependent trade-off in which gains in diagnosis can coincide with losses in localization.

Ask the AI about this article →

Get the latest Large Language Models news every morning

For example, today's edition would include:

  • Claude 5.1 adds song lyric ban after Sony, Warner suitSimon Willison's Weblog · 1h ago
  • US military adds ChatGPT and Grok to GenAI.milTHE DECODER · 1h ago
  • AWS Cloud Quest 2.0 launches with AI virtual customersPublickey · 1h ago

AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.

Free · takes 30 seconds · unsubscribe anytimeWhat is AIToday? →

Ask AI

Ask AI anything about this article. Q&As are published on this page for other readers too.

Related Articles

Next articlePalantir Technologies reports Q1 2026 revenue of $1.633 billion, up 85% year over year, with full-year 2026 guidance raised to $7.65 billion–$7.662 billion.